Expensive Drugs

摘要

Since Jan. 1 shares of what is now OMNI BIO PHARMACEUTICAL (OMBP, 15) have risen 2,600%. That means a $400 million market value for a company with no products, no revenues and a going-concern warning in its financials. Most of the boost came after thernGreenwood Village, Colo, firm did a reverse merger in March, later changing its name from Across America Financial Services, which had tried to be a mortgage broker.